×
Nav 1: 14.614
Date : 21-Mar-2025
Average AUM : 79656.61
| Stock Name | Sector | Value Mn | % of Total Holdings | More Details |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | Pharmaceuticals | 181.9 | 10.90% | |
| ELI LILLY ORD SHS | Foreign equity | 104.7 | 6.27% | |
| Max Healthcare Institute | Hospital | 88.4 | 5.30% | |
| Cipla | Pharmaceuticals | 89 | 5.33% | |
| Apollo Hospitals Enterprises | Hospital | 89.2 | 5.35% | |
| Divis Laboratories | Pharmaceuticals | 85.9 | 5.15% | |
| Dr Reddys Laboratories | Pharmaceuticals | 78.5 | 4.71% | |
| Johnson & Johnson | Foreign equity | 68.7 | 4.12% | |
| Lupin | Pharmaceuticals | 64.3 | 3.85% | |
| AbbVie Inc | Foreign equity | 49.4 | 2.96% | |
| Fortis Healthcare | Hospital | 49.7 | 2.98% | |
| Torrent Pharmaceuticals | Pharmaceuticals | 55.8 | 3.34% | |
| Laurus Labs | Pharmaceuticals | 40.2 | 2.41% | |
| Aurobindo Pharma | Pharmaceuticals | 37.5 | 2.25% | |
| Merck & Co Inc Shs | Foreign equity | 34.6 | 2.07% | |
| Glenmark Pharmaceuticals | Pharmaceuticals | 37.2 | 2.23% | |
| NOVARTIS AG | Foreign equity | 35.5 | 2.13% | |
| Mankind Pharma | Pharmaceuticals | 31.3 | 1.87% | |
| Alkem Laboratories | Pharmaceuticals | 32.3 | 1.93% | |
| Abbott Laboratories | Foreign equity | 23.9 | 1.43% | |
| Thermo Fisher Scientific Inc | Foreign equity | 27.4 | 1.64% | |
| Intuitive Surgical | Foreign equity | 22.7 | 1.36% | |
| Amgen | Foreign equity | 23.1 | 1.38% | |
| Biocon | Pharmaceuticals | 23.3 | 1.40% | |
| Ipca Laboratories | Pharmaceuticals | 24.4 | 1.46% | |
| Novo Nordisk A/S | Foreign equity | 24 | 1.44% | |
| Zydus Lifesciences | Pharmaceuticals | 21.2 | 1.27% | |
| Gilead Sciences | Foreign equity | 22.1 | 1.32% | |
| Danaher Corporation | Foreign equity | 17.7 | 1.06% | |
| Medtronic Plc | Foreign equity | 16.6 | 0.99% | |
| Stryker Corporation | Foreign equity | 16 | 0.96% | |
| Narayana Hrudayalaya | Hospital | 15 | 0.90% | |
| Vertex Pharmaceuticals | Foreign equity | 15.2 | 0.91% | |
| Gland Pharma | Pharmaceuticals | 16.3 | 0.98% | |
| Syngene International | Healthcare research, analytics & technology | 10.2 | 0.61% | |
| Piramal Pharma | Pharmaceuticals | 11 | 0.66% | |
| Ajanta Pharma | Pharmaceuticals | 14.5 | 0.87% | |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals | 12.1 | 0.72% | |
| Global Health | Hospital | 10.1 | 0.61% | |
| Regeneron Pharmaceuticals | Foreign equity | 9.7 | 0.58% | |
| Becton Dickinson and Co | Foreign equity | 7.3 | 0.44% | |
| Suven Pharmaceuticals | Pharmaceuticals | 7.4 | 0.00% | |
| Agilent Technologies Inc | Foreign equity | 4.8 | 0.29% | |
| Iqvia Holdings | Foreign equity | 4.9 | 0.30% | |
| ILLUMINA | Foreign equity | 2.8 | 0.17% | |
| Aster DM Healthcare | Hospital | 15.3 | 0.92% |